IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY. (June 2017) - Bonnet, C.M.; Lamy, T.; Fruchart, C.; Legouill, S.; Gunzer, K.; Gastinne, T.; Jardin, F.; Karlin, L.; Houot, R.; Dupuis, J.; Tilly, H.; Salles, G.